Campus alert status is yellow: For the latest campus alert status, news and resources, visit

Search Close Search
Search Close Search
Page Menu

Ashraf Khan

UMassMed Faculty Page


Title: Diagnostic Test for High Risk Premalignant Breast Lesions. UMMS14-69; Patent Pending.

  • The present invention provides an objective biomarker, SFRP1, for the diagnosis of pre-malignant breast lesions also knows as atypical hyperplasias. The technology also discloses a gene expression profile used for predicting the risk that a pre-malignant breast lesion will advance to invasive breast cancer. Further, methods, assays and kits incorporating the SFRP1 biomarker are provided. 


Innovation TopicsDiagnostics, CancerAtypical hyperplasiaBreast cancer